Latest News- In-Vitro Diagnostics Instruments Market: Immunochemistry is expected to lead the Product segment during 2025-2029

The In-Vitro Diagnostics Instruments Market is being driven by Growing geriatric population

The In-Vitro Diagnostics Instruments Market is expected to grow at a CAGR of 9.8% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 60.9 billion. In the global healthcare landscape, there is a lack of standardization and endorsement for the implementation of decentralized In-Vitro Diagnostic (IVD) testing in primary and outpatient care settings. Portable IVD instruments, which are increasingly gaining popularity due to their technical advancements, are more frequently utilized in Point-of-Lcare (POL) testing. However, this trend necessitates the involvement of key stakeholders, including patients, reimbursement bodies, regulators, and administrators, to recognize the significance of POL testing. The POL market encompasses segments related to actionable infectious disease markers, cardiovascular diseases, and diabetes care. Common infectious disease testing, particularly molecular diagnostics, has been a significant driver of the use of portable molecular diagnostic instruments in POL practice. Many central lab instruments now offer support for POL testing, expanding the options for clinicians seeking in-house testing solutions. 

Get more information on In-Vitro Diagnostics Instruments Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Immunochemistry
  • Clinical microbiology
  • Molecular diagnostics
  • Others
• End-user
  • Hospitals and diagnostic laboratories
  • Academic and research institutes
  • Home care
• Application
  • Infectious diseases
  • Oncology
  • Diabetes
  • Cardiology
  • Others
• Geography
  • North America
    • Canada
    • Mexico
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing geriatric population
• Demand for personalized medicines
• Product launches

However, the market also witnesses some limitations, which are as follows:

• Strained laboratory budgets and lowering reimbursements affecting instrument sales
• Limited sustainability of smaller companies
• Limitations of closed systems in IVD testing

Benefits of Buying Global In-Vitro Diagnostics Instruments Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in In-Vitro Diagnostics Instruments Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The In-Vitro Diagnostics Instruments Market encompasses various technologies and tools used for disease diagnostics, patient monitoring, infection detection, and cancer diagnostics. These instruments employ sample preparation methods and offer test result interpretation. They include cardiovascular, endocrine, immunology diagnostics, and genetic testing. Rapid diagnostic tests, home diagnostic kits, multiplex assays, digital PCR, next-generation sequencing, and liquid biopsy are among the advanced techniques. Lab information systems ensure calibration procedures, maintenance protocols, and troubleshooting guides. Instrument performance, cost-effectiveness metrics, workflow efficiency, data analysis software, clinical decision support, and remote diagnostics are essential considerations.

Market Research Overview

The In-Vitro Diagnostics Instruments Market is a significant segment of the global healthcare equipment industry, encompassing point-of-care testing, immunoassay technology, molecular diagnostic tests, and clinical chemistry analyzers. According to Technavio, this market is a crucial component of the larger global healthcare equipment market, which comprises manufacturers of various diagnostic equipment and devices used in the diagnosis, monitoring, and treatment of diseases. The healthcare equipment market size is determined by the combined revenue generated from these manufacturers across multiple therapy areas. Specifically, the In-Vitro Diagnostics Instruments Market includes advanced, differentiated, and clinically validated devices, such as point-of-care testing systems, immunoassay analyzers, molecular diagnostic instruments, and clinical chemistry analyzers. These devices play a vital role in the diagnosis and monitoring of various diseases, contributing significantly to the overall growth of the global healthcare equipment industry.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/